Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.40 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.40 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16161494 | 0.96 | MEN1 (0.60) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL8468010 | 0.92 | TSHR (0.52) | HTTMEN1KMT2ATHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL5146482 | 0.90 | MEN1 (0.61) | HTTMEN1KMT2ATHRBMAPT | |
| Phosphoric Acid SCHEMBL8824167 | 0.90 | TSHR (0.45) | HTTMEN1KMT2ATHRBMAPT | |
| Triethylene Glycol SCHEMBL5143692 | 0.89 | MEN1 (0.64) | HTTMEN1KMT2ATHRBMAPT | |
| Triethylene Glycol SCHEMBL28536690 | 0.89 | MEN1 (0.64) | HTTMEN1KMT2ATHRBMAPT | |
| Triethylene Glycol SCHEMBL26983266 | 0.89 | MEN1 (0.64) | HTTMEN1KMT2ATHRBMAPT | |
| Tetraethylene Glycol SCHEMBL5142076 | 0.89 | MEN1 (0.64) | HTTMEN1KMT2ATHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL5142109 | 0.89 | MEN1 (0.59) | HTTMEN1KMT2ATHRBMAPT | |
| Phosphoric Acid SCHEMBL8824245 | 0.87 | MEN1 (0.50) | HTTMEN1KMT2ATHRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1835812-B1 | GLYCOPYRROLATE IN COSMETIC PREPARATIONS | BEIERSDORF AG (DE) | 2011-08-17 | — | — | EP | claimed |
| EP-1839645-B1 | Cosmetic or dermatological emulsions containing licochalcone A or an extract of radix glycyrrhizae inflatae containing licochalcone A | BEIERSDORF AG (DE) | 2010-03-03 | — | — | EP | claimed |
| EP-1393707-B1 | Cosmetic composition for cleaning and care of the skin | BEIERSDORF AG (DE) | 2006-05-31 | — | — | EP | claimed |
| US-20040037797-A1 | Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers | BEIERSDORF AG | 2004-02-26 | — | — | US | claimed |
| EP-4398866-A1 | AQUEOUS COMPOSITION COMPRISING A FATTY DIALKYL ETHER, AN ANIONIC SURFACTANT WITH AT LEAST ONE CATIONIC COUNTERION AND A NONIONIC SURFACTANT | L'OREAL (FR) | 2024-07-17 | — | — | EP | disclosed |
| US-20230149289-A1 | COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED ELASTICITY AND EXTENSIBILITY | COVESTRO DEUTSCHLAND AG (DE) | 2023-05-18 | — | — | US | disclosed |
| WO-2023036685-A1 | AQUEOUS COMPOSITION COMPRISING A FATTY DIALKYL ETHER, AN ANIONIC SURFACTANT WITH AT LEAST ONE CATIONIC COUNTERION AND A NONIONIC SURFACTANT | L'OREAL (FR) | 2023-03-16 | — | — | WO | disclosed |
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | CLARIANT INTERNATIONAL LTD. (CH) | 2021-09-07 | — | — | US | disclosed |
| US-10888719-B2 | Active substance combination of creatine and/or creatinine and phenoxyethanol | BEIERSDORF AG (DE) | 2021-01-12 | — | — | US | disclosed |
| US-20200390679-A1 | POLY(VINYLAMINE-VINYLFORMAMIDE) COPOLYMERS AS ANTIPERSPIRANT AGENT | HENKEL AG & CO. KGAA (DE) | 2020-12-17 | — | — | US | disclosed |
| EP-3636686-A1 | COSMETIC FORMULATIONS OR COMPOSITIONS COMPRISING BIODEGRADABLE FILM FORMERS | Covestro Deutschland AG (DE) | 2020-04-15 | — | — | EP | disclosed |
| US-10583079-B2 | Composition for skin hygiene and/or hydration | KAO CORPORATION, S.A. (ES) | 2020-03-10 | — | — | US | disclosed |
| US-20020155076-A1 | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | CLARIANT INTERNATIONAL LTD. (CH) | 2002-10-24 | — | — | US | disclosed |
| US-20020119114-A1 | Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures | BEIERSDORF AKTIENGESELLSCHAFT | 2002-08-29 | — | — | US | disclosed |
| US-6440428-B1 | CREAM FOR PSORIASIS AND CONDYLOMA ACUMINATA TREATMENT | ANALYTECON SA (CH) | 2002-08-27 | — | — | US | disclosed |
| US-6436414-B1 | Active ingredient combinations or adducts of biotin and/or biotin derivatives and cyclodextrins and use of such active ingredient combinations in cosmetic preparations | BEIERSDORF AG (DE) | 2002-08-20 | — | — | US | disclosed |
| US-20020045596-A1 | Active ingredient combinations or adducts of cyclodextrins and at least one quinone and/or at least one hydroquinone and use of such active ingredient combinations in cosmetic preparations | BEIERSDORF AG (DE) | 2002-04-18 | — | — | US | disclosed |
| EP-0587554-B1 | A PODOPHYLLOTOXIN PREPARATION CONTAINING TRIGLYCERIDES | ANALYTECON SA (CH) | 1997-10-08 | — | — | EP | disclosed |
| EP-0587554-A1 | A PODOPHYLLOTOXIN PREPARATION CONTAINING TRIGLYCERIDES. | ANALYTECON SA (CH) | 1994-03-23 | — | — | EP | disclosed |
| WO-1991001717-A1 | A PODOPHYLLOTOXIN PREPARATION CONTAINING TRIGLYCERIDES | ANALYTECON S.A. (CH) | 1991-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149289-A1 | COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED ELASTICITY AND EXTENSIBILITY | POLR1C, CUTA, SUCLG1 | HTT 382/4885MEN1 960/4885KMT2A 1117/4885 |
| US-20020045596-A1 | Active ingredient combinations or adducts of cyclodextrins and at least one quinone and/or at least one hydroquinone and use of such active ingredient combinations in cosmetic preparations | NQO1, RECQL, KEAP1 | HTT 235/4885MEN1 2565/4885KMT2A 3530/4885 |
| US-10888719-B2 | Active substance combination of creatine and/or creatinine and phenoxyethanol | REN, CKMT1A; CKMT1B, CRAT | HTT 2638/4885MEN1 4090/4885KMT2A 951/4885 |
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | GPX4, LPO, CAT | HTT 47/4885MEN1 3224/4885KMT2A 4648/4885 |
| US-20020155076-A1 | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | AGPAT2, ACMSD, POLR1C | HTT 304/4885MEN1 4477/4885KMT2A 1076/4885 |
| US-20020119114-A1 | Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures | LIPA, GLA, DEGS1 | HTT 2257/4885MEN1 1433/4885KMT2A 2016/4885 |
| US-20040037797-A1 | Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers | PHOSPHO1, AGPAT2, AGPAT5 | HTT 247/4885MEN1 3181/4885KMT2A 1398/4885 |
| US-10583079-B2 | Composition for skin hygiene and/or hydration | CUTA, GK, DAGLB | HTT 3517/4885MEN1 4330/4885KMT2A 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.